Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Depreciation & Amortization (CF) (2016 - 2025)

Immucell's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $709472.0 for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 3.62% year-over-year to $709472.0; the TTM value through Dec 2025 reached $2.8 million, up 1.98%, while the annual FY2025 figure was $2.8 million, 1.98% up from the prior year.
  • Depreciation & Amortization (CF) reached $709472.0 in Q4 2025 per ICCC's latest filing, roughly flat from $708667.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $709472.0 in Q4 2025 to a low of $603161.0 in Q4 2021.
  • Average Depreciation & Amortization (CF) over 5 years is $660881.9, with a median of $678268.5 recorded in 2024.
  • Peak YoY movement for Depreciation & Amortization (CF): increased 13.0% in 2023, then dropped 3.27% in 2024.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $603161.0 in 2021, then grew by 0.5% to $606174.0 in 2022, then grew by 13.0% to $684979.0 in 2023, then dropped by 0.05% to $684655.0 in 2024, then rose by 3.62% to $709472.0 in 2025.
  • Per Business Quant, the three most recent readings for ICCC's Depreciation & Amortization (CF) are $709472.0 (Q4 2025), $708667.0 (Q3 2025), and $679037.0 (Q2 2025).